IL125047A - Sustained-release microgranules containing diltiazem as active component - Google Patents

Sustained-release microgranules containing diltiazem as active component

Info

Publication number
IL125047A
IL125047A IL12504796A IL12504796A IL125047A IL 125047 A IL125047 A IL 125047A IL 12504796 A IL12504796 A IL 12504796A IL 12504796 A IL12504796 A IL 12504796A IL 125047 A IL125047 A IL 125047A
Authority
IL
Israel
Prior art keywords
sustained
active component
microgranules containing
release microgranules
containing diltiazem
Prior art date
Application number
IL12504796A
Other languages
English (en)
Other versions
IL125047A0 (en
Original Assignee
Prod Ethiques Ethypharm Sa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9485856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL125047(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Prod Ethiques Ethypharm Sa Lab filed Critical Prod Ethiques Ethypharm Sa Lab
Publication of IL125047A0 publication Critical patent/IL125047A0/xx
Publication of IL125047A publication Critical patent/IL125047A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL12504796A 1995-12-22 1996-12-23 Sustained-release microgranules containing diltiazem as active component IL125047A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9515361A FR2742660B1 (fr) 1995-12-22 1995-12-22 Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
PCT/FR1996/002040 WO1997023219A1 (fr) 1995-12-22 1996-12-23 Microgranules a liberation prolongee contenant du diltiazem comme principe actif

Publications (2)

Publication Number Publication Date
IL125047A0 IL125047A0 (en) 1999-01-26
IL125047A true IL125047A (en) 2003-05-29

Family

ID=9485856

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12504796A IL125047A (en) 1995-12-22 1996-12-23 Sustained-release microgranules containing diltiazem as active component

Country Status (27)

Country Link
US (3) US6228395B1 (ko)
EP (1) EP0868184B1 (ko)
JP (1) JP2000506500A (ko)
KR (1) KR100354054B1 (ko)
CN (1) CN1145488C (ko)
AR (1) AR004410A1 (ko)
AT (1) ATE238798T1 (ko)
AU (1) AU721949B2 (ko)
BG (1) BG63770B1 (ko)
BR (1) BR9612225A (ko)
CA (1) CA2242224C (ko)
DE (1) DE69627880T2 (ko)
DK (1) DK0868184T3 (ko)
EA (1) EA001721B1 (ko)
EE (1) EE04045B1 (ko)
ES (1) ES2198505T3 (ko)
FR (1) FR2742660B1 (ko)
GE (1) GEP20022629B (ko)
HK (1) HK1018400A1 (ko)
HU (1) HU224214B1 (ko)
IL (1) IL125047A (ko)
NO (1) NO324680B1 (ko)
NZ (1) NZ324739A (ko)
PL (1) PL186621B1 (ko)
PT (1) PT868184E (ko)
WO (1) WO1997023219A1 (ko)
ZA (1) ZA9610776B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
FR2831546B1 (fr) * 2001-10-31 2007-03-23 Atofina Materiau polymere thermoplastique pour supports d'enregistrement d'informations audio et/ou optiques
CN1874764B (zh) * 2003-10-10 2012-08-01 埃法尔姆公司 含有银杏提取物的持续释放微粒及其制备方法
US20070122471A1 (en) * 2003-12-25 2007-05-31 Takeda Pharmaceutical Company Limited Method of improving suitability for granulation
JP2005306778A (ja) * 2004-04-21 2005-11-04 Basf Ag 徐放性製剤及びその製造方法
WO2006013431A1 (en) * 2004-07-29 2006-02-09 Pfizer Limited Stable controlled-release pharmaceutical formulation of eletriptan
US8778395B2 (en) * 2005-08-11 2014-07-15 Andrx Labs, Llc Diltiazem controlled release formulation and method of manufacture
WO2007149438A2 (en) * 2006-06-19 2007-12-27 Alpharma, Inc. Pharmaceutical compositions
ITFI20110172A1 (it) 2011-08-08 2013-02-09 Valpharma Sa Formulazione multiparticolata a rilascio modificato di diltiazem hcl.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
DK173505B1 (da) * 1987-02-20 2001-01-15 Pharmatec Internat S R L Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t
JPH07552B2 (ja) * 1987-11-06 1995-01-11 田辺製薬株式会社 持効性製剤
FR2623714B1 (fr) * 1987-11-26 1990-04-20 Ethypharm Sa Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
FR2630647B1 (fr) * 1988-04-27 1991-08-16 Sanofi Sa Microbilles de diltiazem, leur procede de fabrication et compositions pharmaceutiques a liberation prolongee les contenant
US5288505A (en) 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5229135A (en) * 1991-11-22 1993-07-20 Prographarm Laboratories Sustained release diltiazem formulation
US5376384A (en) 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif

Also Published As

Publication number Publication date
CN1207681A (zh) 1999-02-10
US6228395B1 (en) 2001-05-08
WO1997023219A1 (fr) 1997-07-03
ATE238798T1 (de) 2003-05-15
US20020182253A1 (en) 2002-12-05
EA199800593A1 (ru) 1998-12-24
CA2242224C (fr) 2004-01-13
ES2198505T3 (es) 2004-02-01
EE9800197A (et) 1998-12-15
NZ324739A (en) 2000-01-28
FR2742660A1 (fr) 1997-06-27
EE04045B1 (et) 2003-06-16
NO982738L (no) 1998-08-21
US6660296B2 (en) 2003-12-09
KR100354054B1 (ko) 2003-02-14
HU224214B1 (hu) 2005-06-28
DK0868184T3 (da) 2003-08-25
HUP9904129A3 (en) 2000-11-28
EP0868184A1 (fr) 1998-10-07
HUP9904129A2 (hu) 2000-04-28
AR004410A1 (es) 1998-11-04
AU1198397A (en) 1997-07-17
FR2742660B1 (fr) 1998-04-03
KR19990076717A (ko) 1999-10-15
BG102555A (en) 1999-02-26
ZA9610776B (en) 1997-06-30
CA2242224A1 (fr) 1997-07-03
AU721949B2 (en) 2000-07-20
NO982738D0 (no) 1998-06-12
PT868184E (pt) 2003-09-30
IL125047A0 (en) 1999-01-26
DE69627880T2 (de) 2004-03-11
NO324680B1 (no) 2007-12-03
GEP20022629B (en) 2002-02-25
CN1145488C (zh) 2004-04-14
EP0868184B1 (fr) 2003-05-02
HK1018400A1 (en) 1999-12-24
US6383516B1 (en) 2002-05-07
BG63770B1 (bg) 2002-12-29
EA001721B1 (ru) 2001-08-27
PL186621B1 (pl) 2004-02-27
BR9612225A (pt) 1999-07-13
DE69627880D1 (de) 2003-06-05
JP2000506500A (ja) 2000-05-30
PL327567A1 (en) 1998-12-21

Similar Documents

Publication Publication Date Title
EP1018864A4 (en) CAGE FOR TRANSPORTING ANIMALS
IL118165A0 (en) Triangular carrier
IL125047A (en) Sustained-release microgranules containing diltiazem as active component
GB9500691D0 (en) Compounds
GB9504910D0 (en) Compounds
ZA963849B (en) Active compound combinations
PL324408A1 (en) Pesticidal compounds
EP0856314A4 (en) IMMUNODEPRESSOR
GB9504948D0 (en) Compounds
EP0859007A4 (en) CYCLIC HEXAPEPTIDE
SG87744A1 (en) Hydrophobic bioremediants
GB9502540D0 (en) Compounds
GB9616628D0 (en) Animal carrier
GB9515071D0 (en) Microencapsulation
PL310869A1 (en) Compound steel-and-concrete floor
GB9513573D0 (en) Pesticidal compounds
GB9523165D0 (en) Pesticidal compounds
GB9500389D0 (en) Pesticidal compounds
GB9500392D0 (en) Pesticidal compounds
GB9500394D0 (en) Pesticidal compounds
GB9513550D0 (en) Pesticidal compounds
GB9500390D0 (en) Pesticidal compounds
GB9514644D0 (en) Sustained-release formulation
GB9504696D0 (en) Improved carrier
GB9500447D0 (en) Compound

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired